Table 3.

Clinical response rate on systemic radionuclide therapy

Nuclide	Primary tumor	Response, %	Reference
89Sr	n.r.	70–90	[34]
153Sm	n.r.	70–80	[55]
186Re	breast cancer	50	[56]
186Re	breast cancer	92	[34]
89Sr	breast cancer	36	[57]
186Re	prostate cancer	83	[56]

n.r. = Not reported.